At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III
In Brief
An observational study for Breast Cancer. Completed, enrolled 3,000 participants across 24 sites.
Detailed Summary
The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesBrazil
CollaboratorsMinistry of Health, Brazil, Avon Institute
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedJan 2016
Primary CompletionJun 2020
Study CompletionApr 2021
TodayJul 2026
First PostedJan 26, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 15, 2020
Study CompletionApr 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 10.4 years ago